[{"Assets_0_Q1_USD":774915000.0,"CommonStockSharesOutstanding_0_Q1_shares":296694330.0,"EarningsPerShareBasic_1_Q1_USD":0.39,"EarningsPerShareDiluted_1_Q1_USD":0.37,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":71808000.0,"NetIncomeLoss_1_Q1_USD":115857000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":313691000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":296421000.0,"Ticker":"EXEL","CIK":"939767","name":"EXELIXIS, INC.","OfficialName":"Exelixis Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7287350058.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20180502"}]